GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Total Liabilities

Raia Drogasil (BSP:RADL3) Total Liabilities : R$14,507 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Total Liabilities?

Raia Drogasil's Total Liabilities for the quarter that ended in Mar. 2024 was R$14,507 Mil.

Raia Drogasil's quarterly Total Liabilities increased from Sep. 2023 (R$13,591.55 Mil) to Dec. 2023 (R$14,066.11 Mil) and increased from Dec. 2023 (R$14,066.11 Mil) to Mar. 2024 (R$14,506.70 Mil).

Raia Drogasil's annual Total Liabilities increased from Dec. 2021 (R$10,056.70 Mil) to Dec. 2022 (R$11,782.37 Mil) and increased from Dec. 2022 (R$11,782.37 Mil) to Dec. 2023 (R$14,066.11 Mil).


Raia Drogasil Total Liabilities Historical Data

The historical data trend for Raia Drogasil's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Total Liabilities Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,171.84 9,402.47 10,056.70 11,782.37 14,066.11

Raia Drogasil Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,725.66 12,143.72 13,591.55 14,066.11 14,506.70

Raia Drogasil Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Raia Drogasil's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8079.497+(5604.396+382.218
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=14,066

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=20094.412-6028.301
=14,066

Raia Drogasil's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8386.386+(5754.093+366.219
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=14,507

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=20651.653-6144.955
=14,507

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil Total Liabilities Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines